Vitality Watch

Dossier clinicaltrials trial early 12-nov-2026
Small or early-phase human trial or pilot study

Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia

Key claim: A randomized controlled trial protocol evaluates whether a 12-week progressive resistance training program improves sarcopenia outcomes in older adults with type 2 diabetes.

Abstract

A randomized controlled clinical trial that will test how progressive resistance training will impact outcomes of sarcopenia in older patients with type 2 diabetes who have been diagnosed as sarcopenia. The intervention will be 12 weeks in duration with approximately 24 sessions of resistance exercises. Outcome measures will be collected at baseline, 4, 8 weeks and 12 weeks.

Why this matters

A randomized controlled trial protocol evaluates whether a 12-week progressive resistance training program improves sarcopenia outcomes in older adults with type 2 diabetes.

Source

Link

Briefing card

Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia
Stage: trial early · clinicaltrials · 12-nov-2026

A randomized controlled trial protocol evaluates whether a 12-week progressive resistance training program improves sarcopenia outcomes in older adults with type 2 diabetes.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06337357

build build 880 · 2bcef25 · 2026-11-18